Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.
- 2016-12-01
- Review
- American journal of physiology. Gastrointestinal and liver physiology 311(6)
- Sena Bluemel
- Brandon Williams
- Rob Knight
- Bernd Schnabl
- PubMed: 27686615
- DOI: 10.1152/ajpgi.00245.2016
- Low evidence
While both affect humoral inflammation, regression of advanced liver disease or mortality has not been demonstrated.
- Effect
- Beneficial
- Effect size
- Small